Ghana NACOC: CSIR Partnership Boosts 0.3% THC Cannabis Research

• Ghana's Narcotics Control Commission (NACOC) and the Council for Scientific and Industrial Research (CSIR) have strengthened their partnership to advance research and cultivation of cannabis with a maximum 0.3% THC content.
• The collaboration aims to develop industrial and medicinal applications for low-THC cannabis while ensuring strict regulatory oversight to prevent abuse and diversion.
• NACOC will rigorously enforce the regulatory framework, monitoring the entire value chain from seed selection to end-use, to maximize economic benefits without compromising public health and safety.
• CSIR brings extensive research and technical expertise, identifying significant opportunities for Ghana in agriculture, manufacturing, and medicine, and will assist in developing traceability systems.
• Future plans include establishing model greenhouse farms, assessing suitable seedlings, and conducting comprehensive soil and laboratory testing to optimize cultivation and explore applications.

NACOC's regulatory mandate extends far beyond merely issuing cultivation licenses; it encompasses the meticulous monitoring and regulation of the entire value chain.

The Narcotics Control Commission (NACOC) in Ghana has significantly enhanced its partnership with the Council for Scientific and Industrial Research (CSIR) to propel advancements in the research, innovation, and sustainable cultivation of cannabis. This collaboration specifically targets cannabis varieties containing a tetrahydrocannabinol (THC) content not exceeding 0.3 per cent. The overarching goal is to foster the development of both industrial and medicinal applications for this low-THC cannabis, commonly known as hemp, while simultaneously ensuring stringent regulatory oversight to prevent any misuse or diversion of the product. This strategic alliance, reported on September 3, 2026, marks a pivotal step in Ghana's engagement with the regulated cannabis sector.

Major General Maxwell Obuba Mantey, the Director-General of NACOC, affirmed the Commission's commitment to rigorously enforcing the regulatory framework governing the cultivation and utilization of cannabis within the stipulated 0.3 per cent THC limit. He articulated that this initiative aims to enable Ghana to harness the full spectrum of economic, industrial, medicinal, and social advantages offered by a regulated cannabis industry. Crucially, this pursuit of benefits must not come at the expense of public health and safety, a principle NACOC intends to uphold steadfastly. These remarks were made during a key meeting between the leadership of NACOC and CSIR, where discussions primarily revolved around collaborative avenues, particularly scientific inquiry into the medicinal and industrial derivatives of low-THC cannabis.

Major General Mantey underscored the indispensable role of scientific evidence and technical expertise in nurturing Ghana's burgeoning cannabis industry. He emphasized that an effective regulatory system must be firmly grounded in robust research, reliable laboratory testing protocols, and comprehensive traceability mechanisms. NACOC's regulatory mandate, he explained, extends far beyond merely issuing cultivation licenses; it encompasses the meticulous monitoring and regulation of the entire value chain. This includes everything from the initial selection of seeds and the cultivation process to the subsequent processing stages and the ultimate end-use of the product.

This comprehensive approach highlights the Narcotics Control Commission Ghana hemp strategy, ensuring that every step is accounted for. Lawyers and compliance officers should note this detailed oversight, as it signals a structured approach to licensing, cultivation, and traceability that will require careful adherence. The emphasis on preventing abuse and diversion, alongside the strict enforcement of the 0.3% THC threshold, sets a clear precedent for future operations within Ghana's industrial hemp regulation landscape.

Dr. Francis Boateng Agyeinim, Director of the CSIR-Institute of Industrial Research (CSIR-IIR), commended NACOC for its proactive measures in regulating cannabis for industrial and medicinal applications. He highlighted the substantial opportunities that a well-regulated hemp industry presents for Ghana, particularly across sectors such as agriculture, manufacturing, medicine, and other emerging industries. Dr. Agyeinim identified farm traceability as a critical component of the regulatory process, asserting that CSIR possesses the requisite technical expertise to assist NACOC in developing effective systems for tracking licensed farms and their produce.

CSIR has conducted extensive research into hemp and its various derivatives, positioning it to contribute significant scientific knowledge and technical capacity to the sector's development. Dr. Agyeinim also pointed out the inherent potential of Ghanaian soils to support the cultivation of hemp with a high fiber content, which could serve as a valuable raw material for a diverse range of industrial applications. He suggested that hemp fiber could offer an alternative to plastic packaging and could also be explored for use in the production of sanitary products, among other innovative uses, thereby bolstering Ghana medicinal cannabis development and industrial output.

The proposed NACOC CSIR cannabis research partnership outlines several key areas for future collaboration. These include the establishment of model greenhouse farms, which will serve as demonstration sites for best practices in Ghana low-THC cannabis cultivation. The partnership will also concentrate on the production and thorough assessment of suitable seedlings, a crucial step for ensuring quality and consistency.

Furthermore, comprehensive soil testing will be undertaken to identify the most appropriate soil types and geographical locations within Ghana best suited for cultivating cannabis that adheres to the 0.3 per cent THC threshold. Laboratory testing and advanced scientific research will form another cornerstone of this collaborative effort, with both institutions committed to examining the properties, diverse applications, and potential medicinal and industrial benefits of the plant.

Lawyers and compliance officers should monitor the evolving regulatory framework for low-THC cannabis in Ghana, as this partnership signals a structured approach to licensing, cultivation, and traceability. This presents new opportunities for clients in agriculture, manufacturing, and medicine, but also requires careful attention to compliance with strict regulatory oversight and potential new licensing requirements.

Source: Original reporting via Myjoyonline.com